
Posted on 7 月 2, 20247/2/24
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach

Posted on 6 月 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation

Posted on 6 月 7, 20246/7/24
Championing Women’s Health and Equity

Posted on 6 月 3, 20246/3/24
Updated Guidance May Ease MDR Transition for SaMD Manufacturers

Posted on 5 月 12, 20245/12/24
Maximizing Sales Impact in a Hybrid World

Posted on 3 月 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization

Posted on 2 月 26, 20242/26/24